• Eur J Anaesthesiol · Nov 2011

    Randomized Controlled Trial Comparative Study

    Nasotracheal intubation using the Blind Intubation Device in anaesthetised adults with Mallampati class 3: a comparison with the Macintosh laryngoscope.

    • Yu Sun, Jin-Xing Liu, Ye-Sen Zhu, Hui Xu, Yan Huang, and Hong Jiang.
    • Department of Anaesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
    • Eur J Anaesthesiol. 2011 Nov 1;28(11):774-80.

    ContextWe hypothesised that the Blind Intubation Device (BID) would be effective for nasotracheal intubation (NTI) in anaesthetised adults with Mallampati class 3. We also hypothesised that BID may cause less haemodynamic changes due to the avoidance of direct stimulation induced by the Macintosh blade.ObjectiveThe purpose of the study was to compare the effectiveness of the BID with the Macintosh laryngoscope for NTI in anaesthetised adults with Mallampati class 3.DesignA prospective randomised controlled study.SettingOperation unit in a University Hospital in Shanghai. Period of the study was from September to November 2010.Patients Or Other ParticipantsMallampati class 3 adults requiring NTI for elective oral and maxillofacial surgery were randomly assigned to a BID group (n = 25) or a Macintosh laryngoscope group (ML group) (n = 25).InterventionAfter anaesthesia induction, patients were intubated by a single anaesthesiologist experienced in using both devices.Main Outcome MeasuresThe mean arterial pressure (MAP) and heart rate (HR) were recorded at specific time points. NTI duration and success rate was compared. Epistaxis-associated and NTI-associated postoperative complications were assessed.ResultsCompared with baseline values, there was a significant increase in MAP in both the BID and ML groups which persisted significantly longer in the ML group. The BID group showed a significantly attenuated MAP value within 30-60 s. The difference between the maximum MAP and the post-induction value was significantly greater in the ML group than in the BID group (64.4 ± 16.1 vs. 45.9 ± 16.1 mmHg, P = 0.0003). Compared with baseline values, there was a significant increase in HR in both groups which persisted longer in the ML group. There was a significantly higher first attempt success rate in the BID group compared with the ML group (100 vs. 76%, respectively, P = 0.022). The NTI duration was 36 s [interquartile range (IQR) 32-40] in the BID group and 33 s (IQR 25.5-41.5) in the ML group. Epistaxis during NTI was less frequent and less severe in the BID group (P = 0.031).ConclusionIn adults with Mallampati class 3, NTI using the BID caused an attenuated haemodynamic response and showed a higher success rate on the first attempt without increasing adverse events. The BID is an effective alternative to the Macintosh laryngoscope for NTI in anaesthetised adults with Mallampati class 3.Trial RegistrationClinicaltrials.gov identifier: NCT 01170455.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.